This case focuses on Pilleve, a Washington, DC-based digital health company that is taking on prescription opioid abuse and addiction, by offering a secure pill bottle and software that prevents unauthorized use or overuse. As the United States faces a USD 500 billion crisis that has claimed 70,000 lives, Pilleve maintains its solution prevents patient misuse, increases patient compliance, and identifies for doctors at-risk patients before they become addicted.
This case examines co-founder Yossuf Albanawi’s perspective on building a solution for the opioid epidemic and which metrics he can use to measure the success of his end-to-end solution. The primary goal of this case is to introduce the challenges of social entrepreneurship for an immigrant co-founder operating in the healthcare arena. Secondarily, the case offers ways to show traction and create health metrics that payers and investors expect to see. Finally, the case focuses on the value proposition of this solution.